Hyperactivity News and Research

RSS

Axis I disorder risk increased in youth with parental history of BD

Children with a parental history of bipolar disorder are at increased for DSM-IV axis I disorders, research shows.

25 Oct 2012

Neurofeedback enhances a brain network responsible for cognitive-control

A breakthrough study conducted in Canada has found that training of the well-known brainwave in humans, the alpha rhythm, enhances a brain network responsible for cognitive-control.

25 Oct 2012

CHOP tool can help parents and health care providers better treat ADHD

Pediatricians and researchers at The Children's Hospital of Philadelphia's(CHOP) have developed a first-of-its kind tool to help parents and health care providers better treat ADHD (attention deficit-hyperactivity disorder).

24 Oct 2012

Pfizer announces intention to acquire NextWave

Pfizer Inc. today announced its intention to acquire NextWave Pharmaceuticals, a privately held, specialty pharmaceutical company focused on the development and commercialization of unique products for the treatment of attention deficit/hyperactivity disorder (ADHD) and related central nervous system (CNS) disorders.

23 Oct 2012

UCI, Brown work advances quest for novel treatments for inherited disorder

UC Irvine and Brown University researchers have created a new fruit fly model of inherited epilepsy that's providing insights into the mechanisms underlying temperature-dependent seizures while establishing a platform from which to develop therapies for these disorders.

20 Oct 2012

Study to determine if treating mothers can help children at risk for ADHD

University of Illinois at Chicago researchers are conducting a study to determine if treating mothers with Attention Deficit Hyperactivity Disorder -- either with medication or parent training -- will help children at risk for ADHD.

19 Oct 2012

Kids with ADHD tend to feel that they benefit from medications

Children living with attention deficit hyperactivity disorder (ADHD) tend to feel that they benefit from medication to treat the condition and do not feel that the medication turns them into 'robots', according to a report published today. In fact, they report feeling that medication helps them to control their behaviour and make better decisions.

19 Oct 2012

Exercise can help children with ADHD perform better academically

A few minutes of exercise can help children with attention deficit hyperactivity disorder perform better academically, according to a new study led by a Michigan State University researcher.

17 Oct 2012

VOICES of children with ADHD support medication use

Children with attention deficit/hyperactivity disorder benefit from the use of stimulant medication and do not feel that it turns them into “robots,” suggests research.

16 Oct 2012

Men with childhood ADHD have multiple disadvantages throughout their lifetime

A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder (ADHD) had significantly worse educational, occupational, economic and social outcomes in a 33-year follow-up study compared to men who were not diagnosed.

16 Oct 2012

Researchers create mouse model that reproduces brain chemical changes associated with AD

Researchers at Western University have created a mouse model that reproduces some of the chemical changes in the brain that occur with Alzheimer's, shedding new light on this devastating disease.

11 Oct 2012

Contaminated fish pose dietary dilemma for pregnant women

Exposure to low levels of mercury in utero increases a child’s risk for developing attention deficit/hyperactivity disorder, report researchers.

10 Oct 2012

Researchers identify astrocytes as new target for Alzheimer's

Alzheimer's disease is a severe neurodegenerative disease that affects 45% of people over 85 years of age. The research teams of Prof. Jin-Moo Lee at Washington University in Saint Louis, USA, and Prof. Milos Pekny at Sahlgrenska Academy in Gothenburg, Sweden, have identified astrocytes as a novel target for the development of future treatment strategies. The results have just been published in the FASEB Journal.

10 Oct 2012

BDNF deletion plays a critical role in psychiatric disease and obesity

McGill researchers have identified a small region in the genome that conclusively plays a role in the development of psychiatric disease and obesity. The key lies in the genomic deletion of brain-derived neurotrophic factor, or BDNF, a nervous system growth factor that plays a critical role in brain development.

9 Oct 2012

Scientists discover how protein deficiency may be linked to frontotemporal dementia

Using animal models, scientists at the Gladstone Institutes have discovered how a protein deficiency may be linked to frontotemporal dementia (FTD)-a form of early-onset dementia that is similar to Alzheimer's disease. These results lay the foundation for therapies that one day may benefit those who suffer from this and related diseases that wreak havoc on the brain.

9 Oct 2012

Prenatal fish consumption may reduce risk of ADHD-related behaviors

A study of children in the New Bedford, Mass., area suggests that low-level prenatal mercury exposure may be associated with a greater risk of attention-deficit/hyperactivity disorder (ADHD)-related behaviors and that fish consumption during pregnancy may be associated with a lower risk of these behaviors, according to a report published Online First by Archives of Pediatrics & Adolescent Medicine, a JAMA Network publication.

9 Oct 2012

Medicaid news: Florida program caught between feds and state efforts; Ark. begins new payment plans for doctors

The Department of Health and Human Services and Florida officials negotiate changes to the state's Medicaid plan. In the meantime, Arkansas doctors offer a cautious endorsement as the state tries "episodic" payments for some common conditions.

9 Oct 2012

Differentiating features of BD, early-onset ADHD identified

Research findings published in the Journal of Abnormal Child Psychology have identified differentiating features between early-onset bipolar disorder and combined attention-deficit/hyperactivity disorder.

3 Oct 2012

Noven initiates d-Amphetamine Transdermal System Phase 2 study in ADHD

Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced commencement of a Phase 2 study of a d-Amphetamine Transdermal System (d-ATS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. Currently, there is no approved amphetamine-based transdermal treatment option available for ADHD.

3 Oct 2012

Comorbid ADHD, PTSD increases psychiatric disorder risk

Research findings show that comorbid post-traumatic stress disorder in children and young individuals with attention deficit hyperactivity disorder increases the likelihood for psychiatric disorders and psychosocial dysfunction.

2 Oct 2012